Equine type estrogens produced by a pregnant woman carrying a Smith- Lemli-Opitz syndrome fetus

Cedric H L Shackleton, Esther Roitman, Lisa Kratz, Richard I. Kelley

Research output: Contribution to journalArticle

Abstract

The equine-type estriols 1,3,5 (10),7-estratetraene-3,16α, 17 β-triol (16α-hydroxy-17β-dihydroequilin) and 1,3,5(10),6,8-estrapentaene- 3,16α,17β-triol(16α-hydroxy-17β-dihydroequilenin) constituted over half of the estrogens excreted by a woman carrying a Smith-Lemli-Opitz syndrome (SLOS) affected fetus. The steroids were characterized by gas chromatography- mass spectrometry (GC/MS), and mass spectra of the dehydro estriols as trimethylsilyl ethers are illustrated. SLOS is associated with 7- dehydrocholesterol (7DHC), delta 7-reductase deficiency; the enzyme catalyzing the final step in cholesterol biosynthesis. Identification of these equine estrogens show that an estrogen biosynthetic pathway parallel to normal is functional in the feto-placental unit and uses 7DHC as precursor, therefore P450scc, P450c17, and 3βHSD and P450arom are all active on 7- dehydrometabolites. Patients with affected fetuses have low plasma estriol values (probably due to deficient production of the cholesterol precursor) and this is often a warning sign which instigates further evaluation for SLOS. The estriol deficiency is not quantitatively made up by the dehydrometabolites, and the combined excretion was found to be about one- third of the mean of gestational age matched controls. The importance of these findings lies in the potential value of dehydroestriol measurement for non-invasive diagnosis of SLOS at mid-gestation. Currently diagnosis relies on imaging, since SLOS is a malformation syndrome, and measurement of 7DHC levels in amniotic fluid and chorionic villus tissue.

Original languageEnglish (US)
Pages (from-to)1157-1159
Number of pages3
JournalJournal of Clinical Endocrinology and Metabolism
Volume84
Issue number3
StatePublished - 1999

Fingerprint

Smith-Lemli-Opitz Syndrome
Estriol
Horses
Pregnant Women
Estrogens
Fetus
Cholesterol
Ethers
Biosynthesis
Gas chromatography
Mass spectrometry
Chorionic Villi
Steroids
Tissue
Biosynthetic Pathways
Plasmas
Imaging techniques
Amniotic Fluid
Fluids
Gas Chromatography-Mass Spectrometry

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Equine type estrogens produced by a pregnant woman carrying a Smith- Lemli-Opitz syndrome fetus. / Shackleton, Cedric H L; Roitman, Esther; Kratz, Lisa; Kelley, Richard I.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 84, No. 3, 1999, p. 1157-1159.

Research output: Contribution to journalArticle

Shackleton, Cedric H L ; Roitman, Esther ; Kratz, Lisa ; Kelley, Richard I. / Equine type estrogens produced by a pregnant woman carrying a Smith- Lemli-Opitz syndrome fetus. In: Journal of Clinical Endocrinology and Metabolism. 1999 ; Vol. 84, No. 3. pp. 1157-1159.
@article{da01c9eb98bb46e9855a402500f4dd2e,
title = "Equine type estrogens produced by a pregnant woman carrying a Smith- Lemli-Opitz syndrome fetus",
abstract = "The equine-type estriols 1,3,5 (10),7-estratetraene-3,16α, 17 β-triol (16α-hydroxy-17β-dihydroequilin) and 1,3,5(10),6,8-estrapentaene- 3,16α,17β-triol(16α-hydroxy-17β-dihydroequilenin) constituted over half of the estrogens excreted by a woman carrying a Smith-Lemli-Opitz syndrome (SLOS) affected fetus. The steroids were characterized by gas chromatography- mass spectrometry (GC/MS), and mass spectra of the dehydro estriols as trimethylsilyl ethers are illustrated. SLOS is associated with 7- dehydrocholesterol (7DHC), delta 7-reductase deficiency; the enzyme catalyzing the final step in cholesterol biosynthesis. Identification of these equine estrogens show that an estrogen biosynthetic pathway parallel to normal is functional in the feto-placental unit and uses 7DHC as precursor, therefore P450scc, P450c17, and 3βHSD and P450arom are all active on 7- dehydrometabolites. Patients with affected fetuses have low plasma estriol values (probably due to deficient production of the cholesterol precursor) and this is often a warning sign which instigates further evaluation for SLOS. The estriol deficiency is not quantitatively made up by the dehydrometabolites, and the combined excretion was found to be about one- third of the mean of gestational age matched controls. The importance of these findings lies in the potential value of dehydroestriol measurement for non-invasive diagnosis of SLOS at mid-gestation. Currently diagnosis relies on imaging, since SLOS is a malformation syndrome, and measurement of 7DHC levels in amniotic fluid and chorionic villus tissue.",
author = "Shackleton, {Cedric H L} and Esther Roitman and Lisa Kratz and Kelley, {Richard I.}",
year = "1999",
language = "English (US)",
volume = "84",
pages = "1157--1159",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Equine type estrogens produced by a pregnant woman carrying a Smith- Lemli-Opitz syndrome fetus

AU - Shackleton, Cedric H L

AU - Roitman, Esther

AU - Kratz, Lisa

AU - Kelley, Richard I.

PY - 1999

Y1 - 1999

N2 - The equine-type estriols 1,3,5 (10),7-estratetraene-3,16α, 17 β-triol (16α-hydroxy-17β-dihydroequilin) and 1,3,5(10),6,8-estrapentaene- 3,16α,17β-triol(16α-hydroxy-17β-dihydroequilenin) constituted over half of the estrogens excreted by a woman carrying a Smith-Lemli-Opitz syndrome (SLOS) affected fetus. The steroids were characterized by gas chromatography- mass spectrometry (GC/MS), and mass spectra of the dehydro estriols as trimethylsilyl ethers are illustrated. SLOS is associated with 7- dehydrocholesterol (7DHC), delta 7-reductase deficiency; the enzyme catalyzing the final step in cholesterol biosynthesis. Identification of these equine estrogens show that an estrogen biosynthetic pathway parallel to normal is functional in the feto-placental unit and uses 7DHC as precursor, therefore P450scc, P450c17, and 3βHSD and P450arom are all active on 7- dehydrometabolites. Patients with affected fetuses have low plasma estriol values (probably due to deficient production of the cholesterol precursor) and this is often a warning sign which instigates further evaluation for SLOS. The estriol deficiency is not quantitatively made up by the dehydrometabolites, and the combined excretion was found to be about one- third of the mean of gestational age matched controls. The importance of these findings lies in the potential value of dehydroestriol measurement for non-invasive diagnosis of SLOS at mid-gestation. Currently diagnosis relies on imaging, since SLOS is a malformation syndrome, and measurement of 7DHC levels in amniotic fluid and chorionic villus tissue.

AB - The equine-type estriols 1,3,5 (10),7-estratetraene-3,16α, 17 β-triol (16α-hydroxy-17β-dihydroequilin) and 1,3,5(10),6,8-estrapentaene- 3,16α,17β-triol(16α-hydroxy-17β-dihydroequilenin) constituted over half of the estrogens excreted by a woman carrying a Smith-Lemli-Opitz syndrome (SLOS) affected fetus. The steroids were characterized by gas chromatography- mass spectrometry (GC/MS), and mass spectra of the dehydro estriols as trimethylsilyl ethers are illustrated. SLOS is associated with 7- dehydrocholesterol (7DHC), delta 7-reductase deficiency; the enzyme catalyzing the final step in cholesterol biosynthesis. Identification of these equine estrogens show that an estrogen biosynthetic pathway parallel to normal is functional in the feto-placental unit and uses 7DHC as precursor, therefore P450scc, P450c17, and 3βHSD and P450arom are all active on 7- dehydrometabolites. Patients with affected fetuses have low plasma estriol values (probably due to deficient production of the cholesterol precursor) and this is often a warning sign which instigates further evaluation for SLOS. The estriol deficiency is not quantitatively made up by the dehydrometabolites, and the combined excretion was found to be about one- third of the mean of gestational age matched controls. The importance of these findings lies in the potential value of dehydroestriol measurement for non-invasive diagnosis of SLOS at mid-gestation. Currently diagnosis relies on imaging, since SLOS is a malformation syndrome, and measurement of 7DHC levels in amniotic fluid and chorionic villus tissue.

UR - http://www.scopus.com/inward/record.url?scp=0033064938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033064938&partnerID=8YFLogxK

M3 - Article

VL - 84

SP - 1157

EP - 1159

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -